Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Antifungal Drugs Market: By Drug Class: Azoles, Echinocandins, Polyenes, Allylamines, Others; By Indication: Dermatophytosis, Aspergillosis, Candidiasis, Others; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics: Swot Analysis; Competitive Landscape; Industry Events and Developments
Global Antifungal Drugs Market Outlook
The global antifungal drugs market stood at a value of around USD 13.2 billion in 2020. The market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 5% to reach USD 18.8 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Significant Growth of the Azoles Segment to Bolster the Growth of the Antifungal Drugs Industry
Based on drug class, the azoles segment accounts for a significant share in the market and is anticipated to witness a considerable growth in the forecast period. Azoles are used to treat a wide range of conditions, including yeast infection, tinea versicolor, and athlete's foot, and are available in different formulations, such as capsules, lotions, and sterile IV solutions, among others. These drugs offer improved absorption and distribution properties with fewer side effects and less serious drug interactions.
These factors have been contributing to the growth of the segment. Over the forecast period, the rising demand for azoles in combination with other antifungal agents to treat systematic and superficial fungal infections is likely to be a major factor driving the market. In addition to this, the growing cases of candidemia, blastomycosis, systematic candidiasis, and ocular fungal infections, among others are likely to aid the segment growth in the coming years.
North America Accounts for a Significant Share in the Antifungal Drugs Industry
North America accounts for a significant market share in the antifungal drugs industry due to the improved healthcare infrastructure, rise in echinocandin resistance, and the growing cases of fungal infections in the region. The growing pharmaceutical industry and the presence of the leading companies in the region are supporting the market growth in North America. Moreover, the increasing commercialisation of drugs is expected to further contribute to the antifungal drugs industry growth in the region.
Antifungal Drugs: Market Segmentation
Antifungal drugs can be defined as a type of drug that helps eliminate fungal infection from the body with minimum toxic side effects. Antifungal drugs basically act against fungal pathogens and are used in the treatment of fungal infections.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on drug class, the market is segmented into:
- Azoles
- Voriconazole
- Posaconazole
- Isavuconazole (CRESEMBA)
- Others
- Echinocandins
- Caspofungin
- Micafungin (Mycamine/ Funguard)
- Others
- Polyenes
- Amphotericin (AmBisome)
- Others
- Allylamines
- Terbinafine
- Others
- Others
On the basis of indication, the industry is divided into:
- Dermatophytosis
- Aspergillosis
- Candidiasis
- Invasive Candidiasis
- Vulvovaginal Candidiasis (VVC)
- Mouth/Throat/Esophageal Candidiasis
- Others
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Risk of Fungal Infections to Boost the Growth of the Antifungal Drugs Industry
The global market for antifungal drugs is driven by the growing prevalence of fungal infections across the globe. The increasing consumption of unhealthy food, which might compromise the immune system, is likely to increase the risk of fungal infections, which, in turn, is expected to propel the demand for antifungal drugs. Furthermore, the rising geriatric population, which is more susceptible to fungal infections such as ringworm, candidiasis, and systematic mycosis, among others, is significantly contributing to the market growth.
Over the forecast period, the growing investments by the leading pharmaceutical companies to develop novel and more effective drugs for fungal diseases are anticipated to augment the market growth in the forecast period.
Key Industry Players in the Global Antifungal Drugs Market
The report gives a detailed analysis of the following key players in the global antifungal drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Abbott Laboratories
- GlaxoSmithKline PLC
- Novartis AG
- Pfizer Inc.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug Class, Indication, Region |
| Breakup by Drug Class | Azoles, Echinocandins, Polyenes, Allylamines, Others |
| Breakup by Indication | Dermatophytosis, Aspergillosis, Candidiasis, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Abbott Laboratories, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Antifungal Drugs Market Analysis
8.1 Key Industry Highlights
8.2 Global Antifungal Drugs Historical Market (2018-2022)
8.3 Global Antifungal Drugs Market Forecast (2023-2028)
8.4 Global Antifungal Drugs Market by Drug Class
8.4.1 Azoles
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.1.4 Breakup by Type
8.4.1.4.1 Voriconazole
8.4.1.4.2 Posaconazole
8.4.1.4.3 Isavuconazole (CRESEMBA)
8.4.1.4.4 Others
8.4.2 Echinocandins
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.2.4 Breakup by Type
8.4.2.4.1 Caspofungin
8.4.2.4.2 Micafungin (Mycamine/ Funguard)
8.4.2.4.3 Others
8.4.3 Polyenes
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.3.4 Breakup by Type
8.4.3.4.1 Amphotericin (AmBisome)
8.4.3.4.2 Others
8.4.4 Allylamines
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2022)
8.4.4.3 Forecast Trend (2023-2028)
8.4.4.3.1 Terbinafine
8.4.4.3.2 Others
8.4.5 Others
8.5 Global Antifungal Drugs Market by Indication
8.5.1 Dermatophytosis
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Aspergillosis
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Candidiasis
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.3.3.1 Invasive Candidiasis
8.5.3.3.2 Vulvovaginal Candidiasis (VVC)
8.5.3.3.3 Mouth/Throat/Esophageal Candidiasis
8.5.3.3.4 Others
8.5.4 Others
8.6 Global Antifungal Drugs Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Abbott Laboratories
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 GlaxoSmithKline PLC
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Novartis AG
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Pfizer Inc.
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Antifungal Drugs Market: Key Industry Highlights, 2018 and 2028
2. Global Antifungal Drugs Historical Market: Breakup by Drug Class (USD Billion), 2018-2022
3. Global Antifungal Drugs Market Forecast: Breakup by Drug Class (USD Billion), 2023-2028
4. Global Antifungal Drugs Historical Market: Breakup by Indication (USD Billion), 2018-2022
5. Global Antifungal Drugs Market Forecast: Breakup by Indication (USD Billion), 2023-2028
6. Global Antifungal Drugs Historical Market: Breakup by Region (USD Billion), 2018-2022
7. Global Antifungal Drugs Market Forecast: Breakup by Region (USD Billion), 2023-2028
8. North America Antifungal Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
9. North America Antifungal Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
10. Europe Antifungal Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
11. Europe Antifungal Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
12. Asia Pacific Antifungal Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
13. Asia Pacific Antifungal Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Latin America Antifungal Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Latin America Antifungal Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Middle East and Africa Antifungal Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Middle East and Africa Antifungal Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Global Antifungal Drugs Market Structure
Key Questions Answered in the Report
In 2020, the global antifungal drugs market attained a volume of nearly USD13.2 billion.
The market is estimated to grow at a CAGR of 5% between 2023 and 2028.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major drivers of the market include rising population of the geriatrics, commercialisation of antifungal drugs, growing investments by the leading pharmaceutical companies, improved healthcare infrastructure, rise in echinocandin resistance, and growing pharmaceutical industry.
The growing prevalence of fungal infections and increasing consumption of unhealthy food are the key trends guiding the growth of the industry.
Azoles, echinocandins, polyenes, and allylamines, among others are the major drug classes of the market. Azoles is further divided into voriconazole, posaconazole, and isavuconazole (CRESEMBA), among others whereas echinocandins is sub-divided into caspofungin and micafungin (mycamine/ funguard), among others. Among these, polyenes are segmented into amphotericin (ambisome), among others while allylamines is segmented into terbinafine, among others.What are the different indications based on which the market is segmented?Dermatophytosis, aspergillosis and candidiasis, among others are the different indications based on which the market is segmented. Candidiasis is further segmented into invasive candidiasis, vulvovaginal candidiasis (VVC), and mouth/throat/esophageal candidiasis, among others.
The major players in the industry are Abbott Laboratories, GlaxoSmithKline PLC, Novartis AG, and Pfizer Inc., among others.
Analyst Review
The global antifungal drugs market attained a value of USD 13.2 billion in 2020, driven by the rising cases of fungal infections. Aided by the ongoing-public-private partnership agreements in the pharmaceutical industry and increasing consumption of unhealthy food, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 5%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on drug class, the market is divided into azoles, echinocandins, polyenes, and allylamines, among others. Azoles is further divided into voriconazole, posaconazole, and isavuconazole (CRESEMBA), among others whereas echinocandins is sub-divided into caspofungin and micafungin (mycamine/ funguard), among others. Among these, polyenes are segmented into amphotericin (ambisome), among others while allylamines is segmented into terbinafine, among others. On the basis of indication, the market is divided into dermatophytosis, aspergillosis and candidiasis, among others. Candidiasis is further segmented into invasive candidiasis, vulvovaginal candidiasis (VVC), and mouth/throat/esophageal candidiasis, among others. The major regional markets for antifungal drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abbott Laboratories, GlaxoSmithKline PLC, Novartis AG, and Pfizer Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER